Other Species / Isoforms
  OSBPL11 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
V7
_MQGGEPVSTMKVsE
0 1
OSBPL11 (human) _MQGGEPVSTMKVsE V7
OSBPL11 (mouse) _MQGGEPASVMKVsE A7
OSBPL11 (rat) KMQGGEPtSVMKVsE T13-p
S13-p
PVSTMKVsEsEGKLE
0 6
OSBPL11 (human) PVSTMKVsEsEGKLE S13-p
OSBPL11 (mouse) PASVMKVsEsEGKLE S13-p
OSBPL11 (rat) PtSVMKVsEsEGKLE S19-p
S15-p
STMKVsEsEGKLEGQ
Upstream
0 15
Treatment
  • ischemia
OSBPL11 (human) STMKVsEsEGKLEGQ S15-p
OSBPL11 (mouse) SVMKVsEsEGKLEGL S15-p
OSBPL11 (rat) SVMKVsEsEGKLEGL S21-p
T24
GKLEGQATAVtPNKN
0 1
OSBPL11 (human) GKLEGQATAVtPNKN T24
OSBPL11 (mouse) GKLEGLAtAVtPNKN T24-p
OSBPL11 (rat) GKLEGLATAVtPNKN T30
T27-p
EGQATAVtPNKNsSC
Upstream
0 27
Treatment
  • nocodazole
OSBPL11 (human) EGQATAVtPNKNsSC T27-p
OSBPL11 (mouse) EGLAtAVtPNKNSGN T27-p
OSBPL11 (rat) EGLATAVtPNKNSGN T33-p
S32-p
AVtPNKNsSCGGGIS
0 1
OSBPL11 (human) AVtPNKNsSCGGGIS S32-p
OSBPL11 (mouse) PNKNSGNSSCGGAIS S35
OSBPL11 (rat) PNKNSGNSSCGGVIS S41
S43-p
GGISSSSssRGGSAK
0 1
OSBPL11 (human) GGISSSSssRGGSAK S43-p
OSBPL11 (mouse) ISSSSSNSSRGGSAK S48
OSBPL11 (rat) ISSSSSNNSRGGSTK N54
S44-p
GISSSSssRGGSAKG
0 1
OSBPL11 (human) GISSSSssRGGSAKG S44-p
OSBPL11 (mouse) SSSSSNSSRGGSAKG S49
OSBPL11 (rat) SSSSSNNSRGGSTKG S55
S55
SAKGWQYSDHMENVy
0 1
OSBPL11 (human) SAKGWQYSDHMENVy S55
OSBPL11 (mouse) SAKGWQYsDHMESVN S60-p
OSBPL11 (rat) STKGWQYSDHMESVN S66
Y62-p
SDHMENVyGYLMKYT
0 25
OSBPL11 (human) SDHMENVyGYLMKYT Y62-p
OSBPL11 (mouse) sDHMESVNGYLMKYT N67
OSBPL11 (rat) SDHMESVNGYLMKYT N73
Y91
NEAGLLEYFVNEQSR
0 3
OSBPL11 (human) NEAGLLEYFVNEQSR Y91
OSBPL11 (mouse) NEAGLLEyFVNEQSR Y96-p
OSBPL11 (rat) NEAGLLEYFVNEQSR Y102
S170-p
KNNPPLKsRsFsLAs
0 3
OSBPL11 (human) KNNPPLKsRsFsLAs S170-p
OSBPL11 (mouse) KNNPPLKSRsFsLAs S175
OSBPL11 (rat) KNNPPLKSRsFsLAs S181
S172-p
NPPLKsRsFsLAsss
Upstream
0 44
Treatment
  • anti-CD3
  • rapamycin
OSBPL11 (human) NPPLKsRsFsLAsss S172-p
OSBPL11 (mouse) NPPLKSRsFsLAssG S177-p
OSBPL11 (rat) NPPLKSRsFsLAssG S183-p
S174-p
PLKsRsFsLAsssNs
0 41
OSBPL11 (human) PLKsRsFsLAsssNs S174-p
OSBPL11 (mouse) PLKSRsFsLAssGNs S179-p
OSBPL11 (rat) PLKSRsFsLAssGNs S185-p
S177-p
sRsFsLAsssNsPIs
0 24
OSBPL11 (human) sRsFsLAsssNsPIs S177-p
OSBPL11 (mouse) SRsFsLAssGNsPIs S182-p
OSBPL11 (rat) SRsFsLAssGNsPIS S188-p
S178-p
RsFsLAsssNsPIsQ
0 10
OSBPL11 (human) RsFsLAsssNsPIsQ S178-p
OSBPL11 (mouse) RsFsLAssGNsPIsQ S183-p
OSBPL11 (rat) RsFsLAssGNsPISQ S189-p
S179-p
sFsLAsssNsPIsQR
Upstream
0 6
Treatment
  • rapamycin
OSBPL11 (human) sFsLAsssNsPIsQR S179-p
OSBPL11 (mouse) sFsLAssGNsPIsQR G184
OSBPL11 (rat) sFsLAssGNsPISQR G190
S181-p
sLAsssNsPIsQRRP
Upstream
0 109
Treatment
  • anti-CD3
  • ischemia
  • LRRK2-IN-1
  • nocodazole
OSBPL11 (human) sLAsssNsPIsQRRP S181-p
OSBPL11 (mouse) sLAssGNsPIsQRRP S186-p
OSBPL11 (rat) sLAssGNsPISQRRP S192-p
S184-p
sssNsPIsQRRPsQN
0 12
OSBPL11 (human) sssNsPIsQRRPsQN S184-p
OSBPL11 (mouse) ssGNsPIsQRRPsQN S189-p
OSBPL11 (rat) ssGNsPISQRRPsQN S195
S189-p
PIsQRRPsQNAIsFF
Upstream
0 250
Kinase, in vitro:
  • Chk1 (human)
Treatment
  • angiotensin_2
  • EGF
  • LPA
  • metastatic potential
  • nocodazole
  • SB202190
  • U0126
OSBPL11 (human) PIsQRRPsQNAIsFF S189-p
OSBPL11 (mouse) PIsQRRPsQNAMsFF S194-p
OSBPL11 (rat) PISQRRPsQNAISFF S200-p
S194-p
RPsQNAIsFFNVGHs
0 2
OSBPL11 (human) RPsQNAIsFFNVGHs S194-p
OSBPL11 (mouse) RPsQNAMsFFNVGHS S199-p
OSBPL11 (rat) RPsQNAISFFNVGHS S205
S201-p
sFFNVGHsKLQSLSK
0 1
OSBPL11 (human) sFFNVGHsKLQSLSK S201-p
OSBPL11 (mouse) sFFNVGHSKLQSVNK S206
OSBPL11 (rat) SFFNVGHSKLQSVNK S212
S225
VEVREMMSHAEGQQR
0 1
OSBPL11 (human) VEVREMMSHAEGQQR S225
OSBPL11 (mouse) VEVREMMsHAEGQQR S230-p
OSBPL11 (rat) VEVREMMSHAEGQQR S236
S286-p
HASHQKGsLPSGTtI
0 4
OSBPL11 (human) HASHQKGsLPSGTtI S286-p
OSBPL11 (mouse) HASHQKGALPSGTTI A291
OSBPL11 (rat) HASHQKGALPSGTTI A297
T292-p
GsLPSGTtIEWLEPK
0 1
OSBPL11 (human) GsLPSGTtIEWLEPK T292-p
OSBPL11 (mouse) GALPSGTTIEWLEPK T297
OSBPL11 (rat) GALPSGTTIEWLEPK T303
S301-p
EWLEPKIsLSNHYKN
0 2
OSBPL11 (human) EWLEPKIsLSNHYKN S301-p
OSBPL11 (mouse) EWLEPKIPLSNHYKN P306
OSBPL11 (rat) EWLEPKIPLSNHYKN P312
K356-ub
IEDTCDHkEDDLGAV
0 1
OSBPL11 (human) IEDTCDHkEDDLGAV K356-ub
OSBPL11 (mouse) VEDTCDNKEDDLGAV K361
OSBPL11 (rat) IEDTCDNKEDDLGAV K364
K395-ac
LPTFILEkRSLLEMY
0 1
OSBPL11 (human) LPTFILEkRSLLEMY K395-ac
OSBPL11 (mouse) LPTFILEKRSLLEMY K400
OSBPL11 (rat) LPTFILEKRSLLEMY K403
K395-ub
LPTFILEkRSLLEMY
0 6
OSBPL11 (human) LPTFILEkRSLLEMY K395-ub
OSBPL11 (mouse) LPTFILEkRSLLEMY K400-ub
OSBPL11 (rat) LPTFILEKRSLLEMY K403
K655-ub
TKYVDLTkLAVTKKR
0 1
OSBPL11 (human) TKYVDLTkLAVTKKR K655-ub
OSBPL11 (mouse) TKFVDLAKLAVTKKR K660
OSBPL11 (rat) TKYVDLAKLAVTKKR K663
K668-ub
KRVRPLEkQDPFESR
0 1
OSBPL11 (human) KRVRPLEkQDPFESR K668-ub
OSBPL11 (mouse) KRVRPLEKQDPFESR K673
OSBPL11 (rat) KRVRPLEKQDPFESR K676
K738-m1
VYHKPLWkIIPTTQP
0 1
OSBPL11 (human) VYHKPLWkIIPTTQP K738-m1
OSBPL11 (mouse) VYHKPLWKGIPSQPA K743
OSBPL11 (rat) VYHKPLWKGIPSQPA K746